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Abstract 
Purpose: To optimize the extraction conditions for Hu-gan-kang-yuan Formula based on extraction 
rates of baicalein and schisandrin using an orthogonal array design. 
Methods: Ethanol concentration (50 - 70 %), ratio of solvent to raw material (8 - 12 mL/g), and 
extraction time (1 - 3 h) were examined with a three-factor and three-level L9(3)3 orthogonal array 
design. In addition, analysis of variance (ANOVA) was used to evaluate the statistical significance of the 
effects of individual factors on extraction rates of baicalein and schisandrin determined by high 
performance liquid chromatography (HPLC). The number of extractions was further investigated to 
confirm the extraction rate of target compounds based on the optimized conditions.  
Results: The optimized conditions were an ethanol concentration of 70 %; ratio of solvent to raw 
material, 12:1 mL/g; and extraction time of 60 min. Ethanol concentration and ratio of solvent to raw 
material showed significant effects on the extraction of the two compounds (p < 0.05). The number of 
extraction steps, two, was reasonable. The final optimum extraction conditions resulted in 79.48 ± 1.40 
and 88.55 ± 1.85 % of extraction for baicalein and schisandrin, respectively. 
Conclusion: The optimized extraction conditions for baicalein and schisandrin are practicable and 
repeatable, and can be upgraded for pilot-scale production of Hu-gan-kang-yuan preparations.  
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Hepatitis B virus (HBV) infection remains a major 
global health threat [1]. Interferon-α and some 
nucleoside analogues have unavoidable 
drawbacks. Adefovir has relatively high 
resistance during long-term treatment [2]. Thus, 
there is a continuing need to develop further 
effective and safe drugs for treating HBV 
infection.   
 
Hu-gan-kang-yuan pill consists of 12 traditional 
Chinese medicinal materials in a hospital 
preparation and has been used to treat hepatitis 
B, decreasing aminopherase and increasing 
immunity, for many years. However, the 
processing required, directly mixing all the 
powders of medicinal material into pills, inevitably 
results in very large doses (6 g three times per 
day). Further development of Hu-gan-kang-yuan 
formula by optimizing extraction conditions is 
needed. To date, selecting extraction rates of 
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typical active compounds as indicators for 
optimizing extraction conditions has been the 
main extraction scheme in Chinese medicine 
preparation. Baicalein and Schisandrin are both 
typical active ingredients with hepatoprotective 
and antifibrotic effects in Scutellariae radix and 
Chinensis fructus, respectively [3-6].  
 
Orthogonal array design is commonly used to 
optimize conditions for the extraction of Chinese 
medicinal materials based on a reasonable 
number of experiments [7-9]. Here, we sought to 
optimize the extraction conditions of Hu-gan-
kang-yuan formula, based on the extraction rates 
of baicalein and schisandrin. The main process 
parameters (ethanol concentration, ratio of 
solvent to raw material, extraction time and 
numbers of extraction) and their effects on the 
extraction rates of the target compounds were 
studied. A simple and efficient simultaneous 
determination method of baicalein and 




Materials and reagents 
 
The medicinal materials (Schisandrae chinensis 
fructus, Ligustri lucidi fructus, Epimedii folium, 
Isatidis Radix, Polygoni cuspidate rhizome et 
radix, Acanthopanacis senticosi radix et rhizoma 
seu caulis, Bupleuri radix, Moutan cortex, 
Scutellariae radix, Astragali radix, Hominis 
placenta, Taxilli herba) were purchased from 
Kangsheng Medicinal Company (Guanghzou, 
China). They were all identified by Associate 
Professor Zhang Hongwei (Department of 
Medicinal Plants & Pharmacognosy, Southern 
Medical University, Guangzhou, China) 
according to pharmacognostic standards 
documented in Volume I of 2010 Edition of China 
Pharmacopoeia. The samples (Table 1) were 
kept in a desiccator (silica gel as desiccant) at 
room temperature in Pharmaceutical Laboratory, 
Department of Chinese Pharmaceutics, Southern 
Medical University, Guangzhou, China. 
 
Reference standards for baicalein and 
schisandrin (Fig 1) were purchased from National 
Institute for the Control of Pharmaceutical and 
Biological Products, Beijing, China (batch 
numbers 111595-201306 and110857-201010, 
respectively). The purities of the standards were 
98.8 % and 99.4 %, respectively. Acetonitrile was 
chromatographic grade, and phosphoric acid, 
methanol, and ethanol were analytical grade. 
Ultrapure water was provided by Southern 
Medical University (Guangzhou, China). 
 
 
Figure 1: Chemical structure of baicalein (A) and 
schisandrin (B) 
 
Table 1: Medicinal plants used in the study 
 
No. Botanical name 
1 Schisandrae chinensis fructus 
2 Ligustri lucidi fructus 
3 Epimedii folium 
4 Isatidis Radix 
5 Polygoni cuspidate rhizome et radix 
6 Acanthopanacis senticosi radix et 
rhizoma seu caulis 
7 Bupleuri radix 
8 Moutan cortex 
9 Scutellariae radix 
10 Astragali radix 
11 Hominis placenta 
12 Taxilli herba 
 
Preparation of reference/standard solutions 
 
Single-stock solutions of baicalein (6.23 mg/mL) 
and schisandrin (11.30 mg/mL) were prepared. 
The final concentrations of baicalein and 
schisandrin in the mixed standard solution were 
62.3 μg/mL and 113.0 μg/mL, respectively. Three 
quality control standard (QC) samples containing 
baicalein and shisandrin (LQC: 12.46 μg/mL, 
22.6 μg/mL; MQC: 62.3 μg/mL, 113.0 μg/mL and 
HQC: 112.14 μg/mL, 203.4 μg/mL respectively) 
were prepared from stock solutions of baicalein 
and schisandrin with methanol. 
 
Preparation of sample solution 
 
All medicinal materials in Hu-gan-kang-yuan 
formula were ground into particles. One 
formulation amount (total, 104 g) was exactly 
weighed and put into a 2000 mL of round-bottom 
flask, 824 mL 60 % ethanol was added. The 
mixture was extracted for 60 min by reflux. 
Thereafter, 10 mL supernatant was transferred 
and evaporated to dryness at 60 oC over a hot 
water bath. The residue was dissolved in 
methanol and completely transferred to 5 mL of 
volumetric flask and the volume made up to 
scale mark with methanol. Finally, the sample 
solution was filtered with a 0.45 µm-membrane 
filter (Supelco Inc., Bellefonte, PA, USA) before 
injection into the HPLC for analysis. The 
extraction rate (%) of the two compounds was 
calculated as in Eq 1.   
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Extraction rate (%) = (m/m0)100 ………….. (1) 
 
where m (mg) is the amount of baicalein or 
shisandrin in extraction solution, and m0 is the 
amount of baicalein or shisandrin in raw material 
of Schisandrae chinensis fructus and Scutellariae 
radix, respectively. 
 
Preparation of negative control sample  
 
All herbal medicines in Hu-gan-kang-yuan 
Formula, except Schisandrae chinensis fructus 
and Scutellariae radix, were weighed exactly and 
exacted according to the preparation of sample 
solution. The extraction solution was used as 
negative control sample solution to evaluate the 
specificity of analytical method for determining 
baicalein and schisandrin. 
 
Orthogonal array experimental design 
 
Based on the physicochemical property of 
baicalein and schisandrin and other medicinal 
materials in Hu-gan-kang-yuan Formula, a three-
factor and three-level orthogonal array design, 
L9(3)3 , was used. Ethanol concentration, ratio of 
solvent to raw material and extraction time were 
the independent variables selected to optimize 
the extraction conditions of baicalein and 
schisandrin. The variables and their levels are 
reported in Table 2. Nine experiments with 
extraction rates of baicalein and schisandrin 
used as indexes to evaluate the independent 
variables are shown in Table 3. The experiments 
were carried out in random order to minimize any 
effects of unexplained variability in observed 
indexes due to systematic errors. All samples 
were tested in triplicate. 
 




1 2 3 
Ethanol concentration (A, %) 50 60 70 
Ratio of solvent to raw material (B, 
mL/g) 
12 10 8 
Extraction time (C, h) 1 2 3 
 
Number of extractions 
 
Normally, extraction rates increase as number of 
extractions is increased; however, it will increase 
energy consumption and take a large amount of 
time. To avoid an interaction effect between 
extraction time and number of extractions [9], 
three different numbers of extraction under the 
optimized extraction conditions were also studied 




Quantitative analyses of baicalein and 
schisandrin were carried out with an Agilent 1260 
HPLC system equipped with a diode aray 
detector (Agilent Technologies, CA, USA). The 
separation was achieved on a Venusil XBP C18 
(250 × 4.6 mm, 5 µm) (dalian, China) at ambient 
temperature. The mobile phase consisted of 
acetonitrile (solvent A) and 0.01 % phosphoric 
acid in water (solvent B). The gradient used was 
0 - 5 min, 25 % A; 5 - 20 min, 25 -35 % A; 20 - 40 
min, 35 - 50 % A. The flow rate was maintained 
at 1 mL/min, the injection volume was 10 µL and 
the wavelength was 280 nm.  
 
Validation of the HPLC method 
 
Specificity is the ability of a method to 
discriminate between the study analyte(s) and 
other components in the sample. In this study, 
the specificity was demonstrated by successively 
running a mixed reference standard sample of 
baicalein and schisandrin, a sample and a 
negative control sample solution under the same 
conditions. The data for peak area versus 
injection amount were treated by linear 
regression analysis. 2, 5, 10, 15 and 20 μl of the 
mixed standard solution of baicalein and 
schisandrin was injected. The response area (y) 
versus injection amount (x), in the range 0.124 - 
1.246 and 0.226 - 2.26 μg for baicalein and 
schisandrin, respectively, was assessed. The 
intra-day and inter-day precisions (%, RSD) were 
established by analyzing QC samples on day 1 
and on each of three consecutive days in five 
replicates. QC samples of baicalein and 
schisandrin at three different concentrations were 
stored at 4 ºC, analyzed by HPLC after 1, 2 and 
3 days, 1 and 2 weeks and 1 month, and then 
evaluated again by calculating area RSD (%) 
values of baicalein and schisandrin at the 
different time points. Accuracy was evaluated by 
means of recovery assays, carried out by adding 
known amounts of baicaleina and schisandrin 
standard solution to the sample at similar 
concentration in six replicates. The spiked 
amounts of baicalein and schisandrin reference 
standards was 6.23 and 11.3 μg, respectively. 
The original amounts of baicalein and 
schisandrin in the sample solution was 8.35 μg 
and 6.83 μg, respectively. Mean recovery was 
calculated as in Eq 2.  
 
Recovery (%) = {(Ad - Ao)/As} …………….. (2) 
 
where Ad, Ao and As are determined amount, 
original amount and amount spiked, respectively. 
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To assess the statistical significance of the 
effects of individual factors on extraction rates of 
baicalein and schisandrin, an ANOVA was used 
to evaluate the experimental data obtained from 





HPLC analysis and validation 
 
Typical HPLC chromatograms of the reference 
standards of baicalein and schisandrin, sample, 
and a negative control sample are shown in Fig 
2. There are no peaks of baicalein or schisandrin 
in the negative control sample. In addition, their 
peaks in the reference standard and sample 
showed good resolution compared to adjacent 
peaks. The calibration curves of baicalein and 
schisandrin were linear over the injection amount 
of 0.124 - 1.246 μg and 0.226 - 2.26 μg, 
respectively. The calibration curves and 
coefficients of determination (r) were y = 
2715.98x + 17.82 (r = 0.9998) and y = 1721.37x 
+ 10.52 (r=0.9999) for baicalein and schisandrin, 
respectively. The mean recoveries of baicalein 
and schisandrin were 98.27 % (RSD = 2.54 %) 
and 97.18 % (RSD = 1.97 %), respectively. The 
intra-day precisions (RSD values) was in the 
range of 0.27 - 1.22 % and 1.02 - 1.27 %, 
respectively, whereas inter-day precisions were 
in the range of 0.76 - 1.65 % and 1.02 - 1.89 %. 
The RSD values of baicalein and shisandrin 
solution at 4.0 ºC for 1 month were in the range 
of 1.1 - 2.17 % and 0.86 - 1.98 %. 
 
Analysis of experimental design 
 
Because various parameters can potentially 
affect the extraction rates, the optimization of 
experimental conditions is a key step in 
developing an extraction method for baicalein 
and schisandrin from Hu-gan-kang-yuan 
Formula. The three process variables (ethanol 
concentration, ratio of solvent to raw material, 
and extraction time) were considered the most 
important factors. In addition, the focus was on 
the main effects of the factors and not 
interactions among different variables in the 
matrix. The sample obtained from each test was 
analyzed using the validated HPLC method. The 
amounts of shisandrin in the raw material of 
Schisandrae chinensis fructus and baicalein in 
Scutellariae radix were determined using the 
validated method. The experimental and analysis 
results are shown in Tables 3 and 4, 
respectively. 
 




Figure 2: HPLC chromatographic profiles of standards mixture (A) and samples of Hu-gan-kang-yuan Formula 
(B) and negative control sample (C): (1) baicalein, (2) schisandrin 
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1 50 12 1 60.32±0.78 70.29±0.65 
2 50 10 2 58.17±0.43 66.55±0.58 
3 50 8 3 49.96±0.28 54.99±0.49 
4 60 12 2 61.08±0.54 73.76±0.66 
5 60 10 3 58.24±0.62 66.01±0.70 
6 60 8 1 52.01±0.37 61.00±0.63 
7 70 12 3 67.20±0.41 78.42±0.72 
8 70 10 1 64.93±0.55 76.54±0.83 
9 70 8 2 57.26±0.38 65.76±0.74 
 
Table 4: Analysis of L9(3)3 test results 
 
Level  Baicalein A      B      C 
Schisandrin 
A       B         C 
L1 168.45 188.60 177.26 191.82 222.46 207.82 
L2 171.33 181.34 176.51 200.76 209.10 206.07 
L3 189.39 159.23 175.39 220.72 181.74 199.41 
R 20.94 29.37 1.87 28.90 40.72 8.41 
L = Sum of extraction rates for the factors at each level. R = Mmax - Mmin 
 
The maximum extraction rates of baicalein and 
schisandrin were 67.20 ± 0.41 % and 78.42 ± 
0.72 %, respectively (Table 3). Each variable had 
a different influence on the extraction rates of the 
target compounds. Based on the results shown 
in Table 3, it was difficult to select the “best” 
extraction conditions. Further analysis was 
subsequently carried out and the results are 
listed in Table 4. Factor B was the most 
significant factor, according to the R value, while 
Factor C was relatively insignificant. 
     
The significance of each variable was 
determined based on a p-value of < 0.05, and 
the results are summarized in Table 5, along with 
analysis of variance (ANOVA) results. Ethanol 
concentration and the ratio of solvent to raw 
material were significant factors for the extraction 
of baicalein and schisandrin (p < 0.05), while 
extraction time had no significant effect (p > 
0.05). 
 
The extraction efficiency significantly increased 
as the numbers of extractions increased from 1 
to 2 (Table 6), whereas there was only a slight 
increase when the number of extractions was 
increased from 2 to 3 (Table 6). 
 
Table 6: Effect of numbers of extraction (n = 3) 
 
No. of extraction Baicalein (%) Schisandrin (%) 
1 68.47±1.78 79.84±1.56 
2 79.48±1.40 88.55±1.85 




The extraction rates of baicalein and schisandrin 
increased with increasing ethanol concentration. 
Ethanol was selected at the highest 
concentration considering the hepatoprotective 
effect and immunity-enhancing effects of Hu-gan-
kang-yuan formula. There are many 
polysaccharides in this formula, such as 
Astragalus polysaccharides from Astragali radix, 
that display hepatoprotective properties [10], 
immunity-enhancing function [11,12], anti-
inflammatory and antioxidant effects [13-15]. 
Polysaccharides are largely water-soluble and 
their contents decrease with increasing ethanol 
concentration as extraction solvent. Considering 
the maximum extraction rates of baicalein of 
67.20 ± 0.41 % and schisandrin of 78.42 ± 0.72 
% under the optimized extraction conditions, 
 
Table 5: F-values from ANOVA results 
 
Factor  Baicalein Sum of squares  F-value   P-value 
 





A 85.88 173.92 0.006* 145.84 50.13 0.02* 
B 156.01 315.95 0.003* 287.21 98.72 0.01* 
C 0.58 1.18 0.458 13.12 4.51 0.18 
Error 0.49   2.91   
*P < 0.05 
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70 % ethanol was selected as the extraction 
solvent to balance the extraction amounts of 
target compounds and polysaccharides. 
 
The results of ratio of solvent to raw material 
between 8:1 and 12:1 mL/g indicated that the 
solvent volume in the studied range played an 
important role in the extraction of baicalein and 
schisandrin. Generally, a larger solvent volume 
will dissolve constituents more effectively, 
leading to improved extraction yields of target 
compounds. However, from an economic 
perspective, using a large amount of solvent is 
not cost-effective due to the high costs of 
solvents and extra energy consumption. Thus, a 
ratio of solvent to raw material 12 mL/g was 
selected. 
 
Time is a major factor for the evaluation of 
extraction efficiency. A shorter extraction time 
could cause incomplete extraction, while a longer 
extraction time could waste time and solvent. 
Based on the reports of baicalein and 
schisandrin extractions, extraction times of 1, 2 
and 3 h were assessed. The extraction rates 
were only slightly affected as the extraction time 
was increased from 1 to 3 h. Thus, a 1 h 
extraction time was chosen. Considering the 
maximum extraction rates of baicalein and 
schisandrin, the cost of energy and the feasibility 
of experiment, the optimum extraction conditions 
were determined to be an ethanol concentration 
70 %, ratio of solvent to raw material 12 mL/g, 




The effect of variables assessed on the 
extraction rates of baicalein and schisandrin was 
in the rank order: ratio of solvent to raw material 
> ethanol concentration > extraction time. The 
process variables (ethanol concentration and 
ratio of solvent to raw material) were the two 
major factors affecting the extraction rates. 
Moreover, an efficient HPLC method has been 
developed for the simultaneous determination of 
baicalein and schisandrin in the extraction 
solution of Hu-gan-kan-yuan Formula (composed 
of 12 Chinese herbal medicines) with good 
sensitivity, precision and repeatability. The 
results obtained can be used to enhance pilot-
scale production of Hu-gan-kang-yuan Formula 
and for the quality control of baicalein and 
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